摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5S)-5-(aminomethyl)-3-(3-fluoro-4-{4-[(5-nitro-2-furyl)methyl]piperazin-1-yl}phenyl)-1,3-oxazolidin-2-one | 776296-79-8

中文名称
——
中文别名
——
英文名称
(5S)-5-(aminomethyl)-3-(3-fluoro-4-{4-[(5-nitro-2-furyl)methyl]piperazin-1-yl}phenyl)-1,3-oxazolidin-2-one
英文别名
(S)-N-[3-[3-fluoro-4-[N-1-[4-{2-furyl-(5-nitro)methyl}]piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methylamine;(5S)-5-(aminomethyl)-3-[3-fluoro-4-[4-[(5-nitrofuran-2-yl)methyl]piperazin-1-yl]phenyl]-1,3-oxazolidin-2-one
(5S)-5-(aminomethyl)-3-(3-fluoro-4-{4-[(5-nitro-2-furyl)methyl]piperazin-1-yl}phenyl)-1,3-oxazolidin-2-one化学式
CAS
776296-79-8
化学式
C19H22FN5O5
mdl
——
分子量
419.413
InChiKey
ZLVXLEISXAIWNA-HNNXBMFYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    30
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    121
  • 氢给体数:
    1
  • 氢受体数:
    9

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (5S)-5-(aminomethyl)-3-(3-fluoro-4-{4-[(5-nitro-2-furyl)methyl]piperazin-1-yl}phenyl)-1,3-oxazolidin-2-one对氟肉桂酸N-甲基吗啉1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 24.0h, 以18%的产率得到(S)-N-[[3-[3-fluoro-4-[N-1-[4-{2-furyl-(5-nitro)methyl}]piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]-3-(4-fluorophenyl)acrylamide
    参考文献:
    名称:
    Synthesis and biological activity of novel oxazolidinones
    摘要:
    A number of 5-substituted derivatives of Ranbezolid, a novel oxazolidinone were synthesized. Antibacterial activity of the compounds against a number of sensitive and resistant bacteria showed promising results. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.09.054
  • 作为产物:
    描述:
    参考文献:
    名称:
    [EN] OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS
    [FR] DERIVES D'OXAZOLIDINONE COMME ANTIMICROBIENS
    摘要:
    本发明涉及某些式I和II的取代苯基噁唑烷酮以及其合成方法。本发明还涉及含有本发明化合物的药物组合物,作为抗微生物药物。这些化合物是有用的抗微生物剂,对许多人类和兽医病原体具有有效作用,包括革兰氏阳性厌氧细菌,如多重耐药葡萄球菌、链球菌和肠球菌,以及厌氧菌,如拟杆菌属和梭菌属的菌种,以及耐酸菌,如结核分枝杆菌、埃维分枝杆菌和分枝杆菌属。
    公开号:
    WO2004089944A1
点击查看最新优质反应信息

文献信息

  • [EN] OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS<br/>[FR] DERIVES D'OXAZOLIDINONE COMME ANTIMICROBIENS
    申请人:RANBAXY LAB LTD
    公开号:WO2004089944A1
    公开(公告)日:2004-10-21
    The present invention relates to certain substituted phenyl oxazolidinones of formula I and II and to processes for the synthesis of the same. This invention also relates to pharmaceutical compositions containing the compounds of the.present invention as antimicrobials. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathogens, including gram-positive aerobic bacteria such as multiply-resistant staphylococci, streptococci and enterococci as well as anaerobic organisms as Bacterioides spp. and Clostridia spp. species, and acid fast organisms such as Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium spp.
    本发明涉及某些式I和II的取代苯基噁唑烷酮以及其合成方法。本发明还涉及含有本发明化合物的药物组合物,作为抗微生物药物。这些化合物是有用的抗微生物剂,对许多人类和兽医病原体具有有效作用,包括革兰氏阳性厌氧细菌,如多重耐药葡萄球菌、链球菌和肠球菌,以及厌氧菌,如拟杆菌属和梭菌属的菌种,以及耐酸菌,如结核分枝杆菌、埃维分枝杆菌和分枝杆菌属。
  • WO2006/43121
    申请人:——
    公开号:——
    公开(公告)日:——
  • [EN] OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS<br/>[FR] DERIVES D'OXAZOLIDINONE SERVANT D'ANTIMICROBIENS
    申请人:RANBAXY LAB LTD
    公开号:WO2006043121A1
    公开(公告)日:2006-04-27
    [EN] The present invention relates to certain substituted phenyl oxazolidinones and to processes for the synthesis of the same. This invention also relates to pharmaceutical compositions containing the compounds of the present invention as antimicrobials. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathogens, including gram-positive aerobic bacteria such as multiple-resistant staphylococci, streptococci and enterococci as well as anaerobic organisms such as Bacterioides spp. and Clostridia spp. species, and acid fast organisms such as Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium spp.
    [FR] L'invention concerne certaines oxazolidinones phényle substituées et des procédés pour la synthèse de celles-ci. L'invention concerne également des compositions pharmaceutiques contenant les composés de l'invention, servant d'antimicrobiens. Ces composés constituent des agents antimicrobiens utiles, ils sont efficaces contre un certain nombre de pathogènes humains et vétérinaires, notamment des bactéries aérobies Gram positives, notamment des staphylocoques, des streptocoques et des entérocoques multirésistants, ainsi que des organismes anaérobies, notamment les espèces Bacterioides spp. et Clostridia spp., et des organismes rapides acides, notamment Mycobacterium tuberculosis, Mycobacterium avium et Mycobacterium spp.
  • Synthesis and biological activity of novel oxazolidinones
    作者:Biswajit Das、A.V.S. Rajarao、Sonali Rudra、Ajay Yadav、Abhijit Ray、Manisha Pandya、Ashok Rattan、Anita Mehta
    DOI:10.1016/j.bmcl.2009.09.054
    日期:2009.11
    A number of 5-substituted derivatives of Ranbezolid, a novel oxazolidinone were synthesized. Antibacterial activity of the compounds against a number of sensitive and resistant bacteria showed promising results. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多